Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ENDRA Life Sciences Inc. (NDRA) had Weighted-Average Shares Outstanding (Diluted) of 2.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$0.16M |
|
-- |
|
-- |
|
$1.48M |
|
$-1.48M |
|
$1.64M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$-1.48M |
|
$-1.44M |
|
1.32M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.48M |
$0.12 |
|
$0.06 |
|
| Balance Sheet Financials | |
$5.59M |
|
$0.04M |
|
$2.36M |
|
$7.94M |
|
$0.79M |
|
-- |
|
$0.85M |
|
$1.63M |
|
$6.31M |
|
$6.31M |
|
$6.31M |
|
1.50M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
$2.67M |
|
$4.16M |
|
$0.76M |
|
$5.54M |
|
$4.78M |
|
$1.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.53% |
|
2.53% |
|
2.01% |
|
2.53% |
|
$4.21 |
|
$-0.83 |
|
$-0.83 |
|